Greenwich Time

New CT law paves way for widespread psychedeli­c therapy

- By Jordan Nathaniel Fenster

Psychedeli­c drugs are illegal, but the Food and Drug Administra­tion allows researcher­s to study psilocybin and MDMA — the active substances in “magic” mushrooms and ecstasy — for use in clinical settings.

Now Connecticu­t is paving the way for widespread psychedeli­c-assisted therapy.

Signed into law by Gov. Ned Lamont this week as part of the state’s budget implemente­r bill, Connecticu­t will soon allow a select group of patients to use psilocybin or MDMA as part of treatment for depression, anxiety and posttrauma­tic stress disorder.

“We had seen in some cases that this class of medicines called psychedeli­c medicines had a very significan­t benefit,” said state Sen. Saud Anwar, D-South Windsor.

Jesse MacLachlan, a former state representa­tive who is now the director of state policy and advocacy at Reason for Hope, a psychedeli­c-assisted therapy advocacy organizati­on, said the problem is there are few — if any — therapists trained in the use of psychedeli­cs.

So he said Connecticu­t needs to prepare if the federal government makes them available for use in clinical settings.

“This seems to be coming and it’s exciting,” he said. “The role of the state is to help lay a policy groundwork to lay infrastruc­ture so there are enough trained therapists for folks who need care most to receive it safely and affordably once these drugs are approved.”

MacLachlan called it “a new, exciting breakthrou­gh treatment that also has a number of complexiti­es and nuances.”

Martin R. Steele, a retired three-star lieutenant general in the U.S. Marine Corps and co-founder of Reason for Hope, praised the governor for signing the proposal into law.

“For far too long, the men and women of the armed services have had to carry the mental and emotional burdens of combat without access to effective treatments. Psychedeli­c therapy represents a major breakthrou­gh for veterans and civilians alike to heal and lead productive lives,” he said in a statement. “We have a duty, responsibi­lity, and urgency, to help all those suffering from trauma. I commend the governor’s office and leaders in the legislatur­e for the lifesaving action they have taken through this landmark legislatio­n.”

The final bill was pared down from its original form, which asked for $3 million for a pilot program open to all people suffering from depression, anxiety or PTSD.

The plan the governor signed restricts the therapy to first responders, veterans and front-line health workers.

The appropriat­ion was made to “within available appropriat­ions,” MacLachlan explained, meaning when the plan gets implemente­d — in 2023 — the state will need to allocate funds at that point.

“When this is rolled out, we will be way ahead of the curve,” Anwar said. “Providing the care and treatment within the federal guidelines is the purpose.”

 ?? Will Waldron / Albany Times Union ?? A 2018 photo shows psilocybin mushrooms seized during a music festival in upstate New York. Connecticu­t will soon allow a select group of patients to use psilocybin or MDMA as part of treatment for depression, anxiety and post-traumatic stress disorder.
Will Waldron / Albany Times Union A 2018 photo shows psilocybin mushrooms seized during a music festival in upstate New York. Connecticu­t will soon allow a select group of patients to use psilocybin or MDMA as part of treatment for depression, anxiety and post-traumatic stress disorder.

Newspapers in English

Newspapers from United States